Cod.: 7973

Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomized trial in general practice

Tognoni G, Avanzini F, Pangrazzi J, Roncaglioni M C, Bertele' V, de Gaetano G, Caimi V, Tombesi M, Colombo Fabio, Barlera S, PPP - Primary Prevention Project

Lancet  2001 ; 357 : 89-95

IF: 13.251
Published

Cod.: 8312

Adjusting Europe's drug regulation to public health needs

Garattini S, Bertele' V

Lancet  2001 ; 358 : 64-67

IF: 13.251
Published

Cod.: 8337

Predictors of clinical outcome in critical leg ischaemia

Bertele' V, Roncaglioni M C, ICAI

Critical Ischaemia  2001 ; 11 : 93-99

Published

Cod.: 8427

Efficacy, safety, and cost of new anticancer drugs

Garattini S, Bertele' V

BMJ  2002 ; 325 : 269-271

IF: 7.585
Published

Cod.: 8640

New approach to clinical trials and drug registration

Garattini S, Bertele' V

BMJ  2001 ; 323 : 341

IF: 6.629
Published

Cod.: 8764

Toward new legislation on drugs in Europe

Garattini S, Bertele' V

Expert Rev Pharmacoecon Outcomes Res  2002 ; 2 : 51-56

Published

Cod.: 8802

European regulatory policies and medicines and public health needs

Li Bassi L, Bertele' V, Garattini S

Eur J Public Health  2003 ; 13 : 246-251

IF: 1.281
Published

Cod.: 8821

Efficacy, safety and cost of new cardiovascular drugs: a survey

Garattini S, Bertele' V

Eur J Clin Pharmacol  2003 ; 59 : 701-706

IF: 1.972
Published

Cod.: 8944

Ethics of testing drugs with readily available alternatives

Garattini S, de Andres-Trelles F, Bertele' V, Li Bassi L

Lancet  2002 ; 360 : 647

IF: 15.397
Published

Cod.: 8975

Placebo or active control? Either, as long as it is in the patient's interest

Garattini S, Bertele' V, Li Bassi L

WHO Drug Information  2003 ; 17 : 253-256

Published